Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10013)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang ZX, Cao JX, Liu ZP, Cui YX, Li CY, Li D, Zhang XY, Liu JL, Li JL. Combination of chemotherapy and immunotherapy for colon cancer in China: A meta-analysis. World J Gastroenterol 2014; 20(4): 1095-1106 [PMID: 24574784 DOI: 10.3748/wjg.v20.i4.1095] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i4/1095.htm |
| Number | Citing Articles |
| 1 |
John Thomas Palathingal, Basil Sunny, Vismaya Vijayan. Combining Chemotherapy with Immunotherapy in Colorectal Cancer: A Review. Clinical Cancer Drugs 2021; 8(1): 10 doi: 10.2174/2212697X07999201029200025
|
| 2 |
Mei Guo, Jun Dou. Advances and perspectives of colorectal cancer stem cell vaccine. Biomedicine & Pharmacotherapy 2015; 76: 107 doi: 10.1016/j.biopha.2015.10.027
|
| 3 |
Sixun Zhong, Yan Zhang, Xiaomin Lu, Vafa Meftahpour. The Therapeutic Potential of Cytokine-Induced Killer in Patients with Cancer. Journal of Interferon & Cytokine Research 2024; 44(3): 99 doi: 10.1089/jir.2023.0180
|
| 4 |
Lei Zhao, Wen-Jia Wang, Jin-Nan Zhang, Xing-Yi Zhang. 5-Fluorouracil and Interleukin-2 Immunochemotherapy Enhances Immunogenicity of Non-Small Cell Lung Cancer A549 Cells through Upregulation of NKG2D Ligands. Asian Pacific Journal of Cancer Prevention 2014; 15(9): 4039 doi: 10.7314/APJCP.2014.15.9.4039
|
| 5 |
Cuiling Zhou, Donglan Liu, Jie Li, Huanhuan Sun, Xiaobin Zheng, Shuncong Wang, Guobin Hong, Saradhi Mallampati, Hongliu Sun, Xiuling Zhou, Zhibin Cheng, Hongyu Zhang, Haiqing Ma. Chemotherapy plus dendritic cells co-cultured with cytokine-induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: A meta-analysis. Oncotarget 2016; 7(52): 86500 doi: 10.18632/oncotarget.13394
|
| 6 |
Jun-Xia Cao, Xiao-Yan Zhang, Jin-Long Liu, Jun-Li Li, Yi-Shan Liu, Min Wang, Bei-Lei Xu, Zheng-Xu Wang. Validity of combination active specific immunotherapy for colorectal cancer: a meta-analysis of 2993 patients. Cytotherapy 2015; 17(12): 1746 doi: 10.1016/j.jcyt.2015.08.009
|
| 7 |
Si-Yong Qin, Yin-Jia Cheng, Qi Lei, Ai-Qing Zhang, Xian-Zheng Zhang. Combinational strategy for high-performance cancer chemotherapy. Biomaterials 2018; 171: 178 doi: 10.1016/j.biomaterials.2018.04.027
|
| 8 |
Yanlai Sun, Zhen Cao, Junqi Shan, Yang Gao, Xin Liu, Dejian Ma, Zengjun Li. Hsa_circ_0020095 Promotes Oncogenesis and Cisplatin Resistance in Colon Cancer by Sponging miR-487a-3p and Modulating SOX9. Frontiers in Cell and Developmental Biology 2021; 8 doi: 10.3389/fcell.2020.604869
|
| 9 |
Ying Mu, Chang-Hui Zhou, Shuang-Feng Chen, Jie Ding, Ying-Xin Zhang, Ya-Pei Yang, Wei-Hua Wang. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell–cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis. Cytotherapy 2016; 18(9): 1162 doi: 10.1016/j.jcyt.2016.05.015
|
| 10 |
Aysegul YILMAZ, Irmak FERAH OKKAY, Ali TAGHİZADEHGHALEHJOUGHİ. Cancer Suppression by Lymphocytes Activated by Cancer-Mediated Exosomes: an In Vitro Study. International Journal of Life Sciences and Biotechnology 2022; 5(2): 187 doi: 10.38001/ijlsb.1069055
|
| 11 |
Yan-Jie Zhao, Ni Jiang, Qing-Kun Song, Jiang-Ping Wu, Yu-Guang Song, Hong-Mei Zhang, Feng Chen, Lei Zhou, Xiao-Li Wang, Xin-Na Zhou, Hua-Bing Yang, Jun Ren, Herbert Kim Lyerly. Continuous DC-CIK Infusions Restore CD8+Cellular Immunity, Physical Activity and Improve Clinical Efficacy in Advanced Cancer Patients Unresponsive to Conventional Treatments. Asian Pacific Journal of Cancer Prevention 2015; 16(6): 2419 doi: 10.7314/APJCP.2015.16.6.2419
|
| 12 |
Shuang Wu, Yuzhu Gong, Jianfang Chen, Xiang Zhao, Huimin Qing, Yan Dong, Sisi Li, Jianjun Li, Zhe Wang. Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma. Biology Direct 2022; 17(1) doi: 10.1186/s13062-022-00332-y
|
| 13 |
Mona W. Schmidt, Marco J. Battista, Marcus Schmidt, Monique Garcia, Timo Siepmann, Annette Hasenburg, Katharina Anic. Efficacy and Safety of Immunotherapy for Cervical Cancer—A Systematic Review of Clinical Trials. Cancers 2022; 14(2): 441 doi: 10.3390/cancers14020441
|
| 14 |
Tingting Li, Hang Li, Wenxin Xia, Mengyuan Li, Yang Niu, Xueyan Fu, Alessandro Poggi. Investigation of the Effects of Glabridin on the Proliferation, Apoptosis, and Migration of the Human Colon Cancer Cell Lines SW480 and SW620 and Its Mechanism Based on Reverse Virtual Screening and Proteomics. Oxidative Medicine and Cellular Longevity 2023; 2023: 1 doi: 10.1155/2023/1117431
|
| 15 |
XIAO-HANG CHE, CHUN-LIN CHEN, XIAO-LEI YE, GUO-BIN WENG, XIAN-ZHI GUO, WEN-YING YU, JIN TAO, YI-CHEN CHEN, XIAODONG CHEN. Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro. Oncology Reports 2016; 35(3): 1680 doi: 10.3892/or.2015.4506
|
| 16 |
Lucia Signorini, Serena Delbue, Pasquale Ferrante, Marco Bregni. Review on the immunotherapy strategies against metastatic colorectal carcinoma. Immunotherapy 2016; 8(10): 1245 doi: 10.2217/imt-2016-0045
|
| 17 |
Yunqing Xie, Lijie Huang, Luchuan Chen, Xiaowei Lin, Li Chen, Qiuhong Zheng. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment. World Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1278-1
|
| 18 |
Mohamed Rahouma, Nathan Mynard, Massimo Baudo, Sherif Khairallah, Shaikha Al-Thani, Anas Dabsha, Shon Shmushkevich, Osama Shoeib, Mohamed Hossny, Elsayed Eldeeb, Hala Aziz, Naglaa Abdelkarim, Mario Gaudino, Abdelrahman Mohamed, Leonard Girardi, Jun Zhang, Luciano Mutti. Impact of Center Volume on Cardiopulmonary and Mortality Outcomes after Immune-Checkpoint Inhibitors for Cancer: A Systematic Review and Meta-Analysis. Cancers 2024; 16(6): 1136 doi: 10.3390/cancers16061136
|
| 19 |
Ru Ma, Jie-tao Chen, Xiao-yue Ji, Xiao-li Xu, Qing Mu. Hydroxypropyl-β-Cyclodextrin Complexes of Styryllactones Enhance the Anti-Tumor Effect in SW1116 Cell Line. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00484
|
| 20 |
Min Wang, Jun-Xia Cao, Jian-Hong Pan, Yi-Shan Liu, Bei-Lei Xu, Duo Li, Xiao-Yan Zhang, Jun-Li Li, Jin-Long Liu, Hai-Bo Wang, Zheng-Xu Wang, Nupur Gangopadhyay. Adoptive Immunotherapy of Cytokine-Induced Killer Cell Therapy in the Treatment of Non-Small Cell Lung Cancer. PLoS ONE 2014; 9(11): e112662 doi: 10.1371/journal.pone.0112662
|
| 21 |
Fu-Sheng Gao, Yu-Tao Zhan, Xu-Dong Wang, Chuan Zhang. Enhancement of anti-tumor effect of plasmid DNA-carrying MUC1 by the adjuvanticity of FLT3L in mouse model. Immunopharmacology and Immunotoxicology 2018; 40(4): 353 doi: 10.1080/08923973.2018.1498099
|
| 22 |
Nirjari Kothari, Humzah Postwala, Aanshi Pandya, Aayushi Shah, Yesha Shah, Mehul R. Chorawala. Establishing the applicability of cancer vaccines in combination with chemotherapeutic entities: current aspect and achievable prospects. Medical Oncology 2023; 40(5) doi: 10.1007/s12032-023-02003-y
|
| 23 |
Yu Zhang, Meng Zhang, Fudong Yu, Su Lu, Huimin Sun, Huamei Tang, Zhihai Peng. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0261-3
|
| 24 |
Xin Zhao, Xia Feng, Cun Wang, Deguang Peng, Kai Zhu, Jia-Le Song. Anticancer activity of Nelumbo nucifera stamen extract in human colon cancer HCT-116 cells in vitro. Oncology Letters 2017; 13(3): 1470 doi: 10.3892/ol.2016.5547
|
| 25 |
Zheng-Xu Wang, Jun-Li Li, Jun-Xia Cao, Yi-Shan Liu, Duo Li, Xiao-Yan Zhang, Min Wang, Min Wu, Bei-Lei Xu, Jin-Long Liu, Hai-Bo Wang. Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysis. Immunotherapy 2014; 6(6): 787 doi: 10.2217/imt.14.41
|
| 26 |
Rachel C Newsome, Ye Yang, Christian Jobin. The microbiome, gastrointestinal cancer, and immunotherapy. Journal of Gastroenterology and Hepatology 2022; 37(2): 263 doi: 10.1111/jgh.15742
|
| 27 |
Guangzhi He, Chenhong Zheng, Huiping Huo, Huiming Zhang, Zhiquan Zhu, Junlai Li, Hongpeng Zhang. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis. International Immunopharmacology 2016; 40: 436 doi: 10.1016/j.intimp.2016.09.015
|
| 28 |
Sare Hosseini, NamPhong Nguyen, Mohammad Mohammadianpanah, Sepideh Mirzaei, Ali Mohammad Bananzadeh. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study. Journal of Gastrointestinal Cancer 2019; 50(4): 716 doi: 10.1007/s12029-018-0136-x
|
| 29 |
Xiao-peng Lan, You-gen Chen, Zheng Wang, Chuan-wei Yuan, Gang-gang Wang, Guo-liang Lu, Shao-wei Mao, Xun-bo Jin, Qing-hua Xia. Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients. Journal of Zhejiang University-SCIENCE B 2015; 16(9): 743 doi: 10.1631/jzus.B1500003
|
| 30 |
Yi Zheng, Bicheng Hu, Shenggao Xie, Xiaofan Chen, Yuqian Hu, Wanping Chen, Shanshan Li, Bo Hu. Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models. Cytotherapy 2017; 19(5): 617 doi: 10.1016/j.jcyt.2017.01.008
|
| 31 |
Xiaoling LUO, Yingying WANG, Zhenhua LU, Rong XU. The application of continuous nursing in patients with enterostomy is beneficial to improve self-care ability, quality of life and reduce the incidence of complications. Minerva Surgery 2024; 79(2) doi: 10.23736/S2724-5691.21.09331-X
|
| 32 |
Xingchun Gao, Yajing Mi, Na Guo, Hao Xu, Lixian Xu, Xingchun Gou, Weilin Jin. Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00774
|
| 33 |
Linghua Chen, Xiaoyan Zhang. Primary analysis for clinical efficacy of immunotherapy in patients with pancreatic cancer. Immunotherapy 2016; 8(2): 223 doi: 10.2217/imt.15.105
|
| 34 |
Zhengyun Zou, Lianjun Zhao, Yu Ren, Shiyao Du. Personalized Management of Gastric Cancer. 2017; : 149 doi: 10.1007/978-981-10-3978-2_11
|